Oral contraceptive pills must be avoided in patients with lipodystrophy as they worsen lipid profile. Switching to efavirenz or withdrawing protease inhibitors is useful in the treatment of HIV associated lipodystrophy.

Tesamorelin, a growth hormone-releasing factor analog a growth hormone-releasing factor analog has been approved by the FDA for treatment of HIV associated lipodystrophy.